Bandingkan Harga & Kinerja Wijaya Cahaya Timber Tbk. (FWCT) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Wijaya Cahaya Timber Tbk. dan Organon Pharma Indonesia Tbk.: Wijaya Cahaya Timber Tbk. diperdagangkan di Rp92 (kapitalisasi pasar 180,6 M, volume 24 jam 4,54 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Wijaya Cahaya Timber Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| FWCT | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 180,6 M | 104,4 M |
Volume | 4,54 jt | — |
Lot | 45,37 rb | — |
Perputaran | 409,51 jt | — |
Harga Rata-rata | 90,26 | — |
Nilai Transaksi | 409,51 jt | — |
Harga Ekuilibrium Indikatif | 92 | — |
Volume Ekuilibrium Indikatif | 2,76 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Wijaya Cahaya Timber Tbk.
PT Wijaya Cahaya Timber Tbk. (“the Company”) was established on March 8, 2017, based on Notarial Deed No.6 dated of Notary Rosdiana, S.H., Notary in Bekasi. PT Fortuna Anugrah Sumber Terpadu, the Company's major shareholder and the ultimate parent entity. The Company started its commercial production in March 2018.
Selengkapnya di halaman FWCT →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
